Non Replicatig Viral Vector

Adeno-based

Gamaleya Research Institute

SARS-CoV-2

Phase 1

NCT04436471 NCT04437875

Protein Subunit

Native like Trimeric subunit Spike Protein vaccine

Clover Biopharmaceuticals Inc./GSK/Dynavax

SARS-CoV-2

Phase 1

NCT04405908

HIV, REV Influenza

Protein Subunit

Recombinant spike protein with Advax™ adjuvant

Vaxine Pty Ltd/Medytox

SARS-CoV-2

Phase 1

NCT04453852

Protein Subunit

Molecular clamp stabilized Spike protein with MF59 adjuvant

University of Queensland/CSL/Seqirus

SARS-CoV-2

Phase 1 ACTRN12620000674932p

Nipah, influenza, Ebola, Lassa

RNA

LNP-nCoVsaRNA

Imperial College London

SARS-CoV-2

Phase 1

ISRCTN17072692

EBOV; LASV, MARV, Inf (H7N9), RABV

RNA

mRNA

Curevac

SARS-CoV-2

Phase 1

NCT04449276

RABV, LASV, YFV; MERS, InfA, ZIKV, DENV, NIPV

RNA

mRNA

People’s Liberation Army (PLA) Academy of Military Sciences/Walvax Biotech.

SARS-CoV-2

Phase 1 ChiCTR2000034112

VLP

Plant-derived VLP adjuvanted with GSK or Dynavax adjs.

Medicago Inc.

SARS-CoV-2

Phase 1 NCT04450004

Flu, Rotavirus, Norovirus, West Nile virus, Cancer